Kiromic BioPharma, Inc. Common Stock (KRBP)

KRBP was delisted on the 13th of September, 2023.

• Market cap: $1.71M
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Kiromic BioPharma Inc is a biotechnology company. It is an artificial intelligence (AI) driven, end-to-end allogeneic cell therapy company, currently developing the multi-indication allogeneic T cell therapy that exploits the natural potency of the Gamma Delta T cell (GDT) to target solid tumors. The company is a gene-editing which utilizes artificial intelligence and a proprietary neural network platform with a therapeutic focus on immuno-oncology.

Employees: 31